Cart
sales@molnova.com
Arundic Acid
CAS No. 185517-21-9
Arundic Acid ( ONO 2506; (R)-2-Propyloctanoic acid )
Catalog No. M23845 CAS No. 185517-21-9
Arundic Acid is an astrocyte-modulating agent, delays the expansion of cerebral infarcts by modulating the activation of astrocytes through inhibition of S-100β synthesis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 35 | In Stock |
|
| 5MG | 56 | In Stock |
|
| 10MG | 87 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameArundic Acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionArundic Acid is an astrocyte-modulating agent, delays the expansion of cerebral infarcts by modulating the activation of astrocytes through inhibition of S-100β synthesis.
-
DescriptionArundic Acid is an astrocyte-modulating agent, delays the expansion of cerebral infarcts by modulating the activation of astrocytes through inhibition of S-100β synthesis.
-
SynonymsONO 2506; (R)-2-Propyloctanoic acid
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number185517-21-9
-
Formula Weight186.3
-
Molecular FormulaC11H22O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:150 mg/mL (805.20 mM; Need ultrasonic)
-
SMILESCCCCCC[C@H](C(=O)O)CCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tomoyuki Hasegawa, et al. Process Development of ONO-2506:? A Therapeutic Agent for Stroke and Alzheimer's Disease. Org. Process Res. Dev.200372168-171.
molnova catalog
related products
-
Rusalatide acetate
Rusalatide acetate (TP508 amide acetate), a regenerated peptide, alleviates radiation-induced gastrointestinal injury by activating stem cells and protecting recess integrity.
-
Geranyl acetate
Geranyl acetate is a monoterpene that has been found in C. sativa with diverse biological activities.
-
TAS-102
TAS-102 is an investigational drug candidate for metastatic colorectal Y. It contains trifluridine (TFT) and Tipiracil hydrochloride (TTP) in a molar ratio of 2:1.
